Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Susan P. Foy"'
Autor:
Susan P. Foy, Kyle Jacoby, Daniela A. Bota, Theresa Hunter, Zheng Pan, Eric Stawiski, Yan Ma, William Lu, Songming Peng, Clifford L. Wang, Benjamin Yuen, Olivier Dalmas, Katharine Heeringa, Barbara Sennino, Andy Conroy, Michael T. Bethune, Ines Mende, William White, Monica Kukreja, Swetha Gunturu, Emily Humphrey, Adeel Hussaini, Duo An, Adam J. Litterman, Boi Bryant Quach, Alphonsus H. C. Ng, Yue Lu, Chad Smith, Katie M. Campbell, Daniel Anaya, Lindsey Skrdlant, Eva Yi-Hsuan Huang, Ventura Mendoza, Jyoti Mathur, Luke Dengler, Bhamini Purandare, Robert Moot, Michael C. Yi, Roel Funke, Alison Sibley, Todd Stallings-Schmitt, David Y. Oh, Bartosz Chmielowski, Mehrdad Abedi, Yuan Yuan, Jeffrey A. Sosman, Sylvia M. Lee, Adam J. Schoenfeld, David Baltimore, James R. Heath, Alex Franzusoff, Antoni Ribas, Arati V. Rao, Stefanie J. Mandl
Publikováno v:
Nature, vol 615, iss 7953
T cell receptors (TCRs) enable T cells to specifically recognize mutations in cancer cells1–3. Here we developed a clinical-grade approach based on CRISPR–Cas9 non-viral precision genome-editing to simultaneously knockout the two endogenous TCR g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd691b6fa2cf73c26cc536f7201c6b0c
https://escholarship.org/uc/item/2g96s8v7
https://escholarship.org/uc/item/2g96s8v7
Autor:
Susan P Foy, Barbara Sennino, Tracy dela Cruz, Joseph J Cote, Evan J Gordon, Felicia Kemp, Veronica Xavier, Alex Franzusoff, Ryan B Rountree, Stefanie J Mandl
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0150084 (2016)
Poxvirus-based active immunotherapies mediate anti-tumor efficacy by triggering broad and durable Th1 dominated T cell responses against the tumor. While monotherapy significantly delays tumor growth, it often does not lead to complete tumor regressi
Externí odkaz:
https://doaj.org/article/cc7e12682bbf4a1697d92a736c69d78a
Autor:
James Bradley Breitmeyer, Susan P. Foy, Alex Franzusoff, Stefanie Mandl, Evan Gordon, Ryan Rountree, Tracy dela Cruz, Erica Trent, Alain Delcayre, Joseph Cote
Publikováno v:
Cancer Immunology, Immunotherapy
The dramatic clinical benefit of immune checkpoint blockade for a fraction of cancer patients suggests the potential for further clinical benefit in a broader cancer patient population by combining immune checkpoint inhibitors with active immunothera
Autor:
Stefanie Mandl, Songming Peng, Kyle Jacoby, Andrew Conroy, Fabrizia Urbinati, Tim Park, Diana Nguyen, Alex Franzusoff, Bhamini Purandare, Michael T. Bethune, Olivier Dalmas, Susan P. Foy, Theresa Hunter, Adam J. Litterman, Barbara Sennino, Robert Moot, William Lu
Publikováno v:
Cancer Research. 79:1433-1433
Clinical benefit observed with immuno-oncology trials often depends on the unleashing of a pre-existing intrinsic T cell immune response in each cancer patient. The targets of these intrinsic T cells are commonly ascribed to recognition of patient-sp
Autor:
William Lu, Olivier Dalmas, Fabrizia Urbinati, Michael T. Bethune, Theresa Hunter, Alex Franzusoff, Songming Peng, Diana Nguyen, Susan P. Foy, Robert Moot, Kyle Jacoby, Barbara Sennino, Bhamini Purandare, Adam J. Litterman, Albert K. Tai, Stefanie Mandl, Andrew Conroy
Publikováno v:
Cancer Research. 79:4783-4783
Methods used to engineer cells for adoptive cell therapies (ACT) utilizing receptors that are constant across many patients (CAR or shared Ag TCRs) typically rely on Lenti-, retro-, or adeno-associated virus to deliver specificity-altering sequences
Autor:
Ryan Rountree, Evan Gordon, Veronica Xavier, Susan P. Foy, Joseph Cote, Stefanie Mandl, Tracy dela Cruz, Barbara Sennino, Alex Franzusoff, Felicia Kemp
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 2, p e0150084 (2016)
PLoS ONE, Vol 11, Iss 2, p e0150084 (2016)
Poxvirus-based active immunotherapies mediate anti-tumor efficacy by triggering broad and durable Th1 dominated T cell responses against the tumor. While monotherapy significantly delays tumor growth, it often does not lead to complete tumor regressi
Autor:
Susan P. Foy, Vinod Labhasetwar
Publikováno v:
Biomaterials. 32:9155-9158
Iron-oxide nanoparticles facilitate cancer diagnosis through enhanced contrast, selectively enhance tumor cell death with magnetic hyperthermia, and improve drug delivery with magnetic drug targeting. One application that remains largely unexplored i
Publikováno v:
Molecular Pharmaceutics. 7:1880-1898
Next to surgical resection, tumor ablation is a commonly used intervention in the treatment of solid tumors. Tumor ablation methods include thermal therapies, photodynamic therapy, and reactive oxygen species (ROS) producing agents. Thermal therapies
Publikováno v:
Journal of Oral and Maxillofacial Surgery. 62:1118-1124
Purpose This study was designed to assess the impact of “pain and swelling” associated with third molars on patients’ quality of life before surgery. Patients and Methods The data for these analyses were obtained from a larger ongoing study des
Autor:
Raymond P. White, Shawn M. Conrad, Daniel A. Shugars, Ceib Phillips, Robert D. Marciani, Susan P. Foy
Publikováno v:
Journal of Oral and Maxillofacial Surgery. 62:15-21
Purpose: We sought to compare recovery for clinical and health-related quality of life (HRQOL) outcomes after third molar surgery in patients treated with or without intravenous antibiotics at surgery. Patients and Methods: Fifty-six patients at leas